Betnovate

Betamethasone valerate

Betnovate cream/oint Relief of the inflammatory & pruritic manifestations of steroid responsive dermatoses. Atopic dermatitis (including infantile atopic dermatitis), nummular dermatitis (discoid eczema), prurigo nodularis, psoriasis (excluding widespread plaque psoriasis), lichen simplex chronicus (neurodermatitis) & lichen planus, seborrhoeic dermatitis, irritant or allergic contact dermatitis, discoid lupus erythematosus, adjunct to systemic steroid therapy in generalised erythroderma, insect bite reactions. Betnovate Scalp Application Psoriasis, seborrhoea capitis & inflammation associated w/ severe dandruff.

Betnovate cream/oint Adult (including elderly) & childn >1 yr Apply once daily to bd up to 4 wk until improvement occurs. Betnovate Scalp Application Apply sparingly to the scalp night & morning. Apply once a day or less frequently to sustain improvement.

Hypersensitivity. Dermatoses in infant <1 yr, including dermatitis. Betnovate cream/oint Untreated cutaneous infections, rosacea, acne vulgaris, pruritus w/o inflammation, perianal & genital pruritus, perioral dermatitis. Betnovate Scalp Application Scalp infections.

History of local hypersensitivity to other corticosteroids. Avoid abrupt withdrawal. Gradually w/draw in case of hypercortisolism (Cushing's syndrome) & reversible hypothalamic-pituitary-adrenal (HPA) axis suppression. Avoid contact w/ eyes. Pregnancy & lactation. Avoid long-term use in childn <12 yr, treatment courses should be limited to 5 days. Betnovate cream/oint Allergic reactions to chlorocresol & local skin reactions to cetostearyl alcohol. Avoid application to a large surface area, or use on occluded areas of skin eg, on intertriginous areas or under occlusive dressings, or use on thin skin areas eg, face, or use on broken skin or other conditions where there is impaired skin barrier. Betnovate Scalp Application Avoid smoking during application; avoid fire, flame & heat including use of hair dryer after application. Caution in patients w/ psoriasis. Occlusive dressings.

Pruritus, local skin burning/skin pain.

Increased systemic exposure w/ drugs that can inhibit CYP3A4 eg, ritonavir & itraconazole.

Topical Corticosteroids / Psoriasis, Seborrhea & Ichthyosis Preparations

D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.

P₁S₁S₃